<DOC>
	<DOCNO>NCT01520142</DOCNO>
	<brief_summary>The purpose study evaluate anti-inflammatory property JNJ-26528398 use intravenous ( IV ) endotoxin-induced model acute , transient inflammation .</brief_summary>
	<brief_title>Safety , Tolerability Pharmacodynamic Activity JNJ-26528398 Healthy Male Participants</brief_title>
	<detailed_description>This 2-part , single center , double-blind study ( neither physician participant know treatment participant receives ) . Part 1 design evaluate safety , tolerability , pharmacokinetics ( level drug blood ) dose regimen investigational drug ( JNJ-26528398 ) prior use Part 2 . In Part 1 , participant assign chance receive either 3 mg/day JNJ-26528398 ( 6 participant ) placebo ( 3 participant ) 7 consecutive day stay clinic 10 day . Placebo inactive substance compare drug test whether drug real effect . Part 2 design evaluate anti-inflammatory property JNJ-26528398 measure marker inflammation blood intravenous ( IV ) administration substance ( endotoxin ) activate immune system temporarily cause flu-like symptom . In Part 2 , participant assign chance receive 3 mg/day JNJ-26528398 ( 6 participant ) placebo ( 4 participant ) 7 consecutive day stay clinic 10 day . Endotoxin give last day study drug administration . Participants remain bed least 6 hour endotoxin administration closely monitor study personnel .</detailed_description>
	<criteria>Nonsmoker Be good health basis physical examination , medical history , electrocardiogram ( ECG ) Must good exercise tolerance Have body mass index 1829 kg/m2 , inclusive , body weight 60 85 kg , inclusive Have history consistent dental hygiene dental care Must adhere require contraception ( subject partner , applicable ) study 3 month study Must agree donate sperm study 3 month study Is currently enrol investigational study , recently receive investigational drug ( include investigational vaccine ) , donate blood within 3 month Has vaccination within past 3 month Has history significant drug alcohol abuse within past 2 year positive drug screen Blood donation within past 3 month Part 2 : Has receive endotoxin within past 3 month , know allergy history significant adverse reaction endotoxin excipients lactose polyethylene glycol 6000</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Healthy participant</keyword>
	<keyword>Pharmacodynamic</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Intravenous Endotoxin-Induced Model</keyword>
	<keyword>Acute Inflammation</keyword>
	<keyword>JNJ-26528398</keyword>
	<keyword>Anti-inflammatory</keyword>
</DOC>